Lornoxicam
Alternative Names: Bosporon; Chlortenoxicam; HN 10000; RO 139297; Safem; TS 110; XefoLatest Information Update: 08 Feb 2019
At a glance
- Originator Roche
 - Developer POZEN; Takeda Pharmaceuticals International GmbH
 - Class Antirheumatics; Nonsteroidal anti-inflammatories; Small molecules; Thiazines
 - Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
 
- 
          
            
              Orphan Drug Status
              No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
 - New Molecular Entity Yes
 
Highest Development Phases
- Marketed Neuropathic pain; Osteoarthritis; Pain; Postoperative pain; Rheumatic disorders
 - Discontinued Migraine